BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38584701)

  • 1. On the Influence of Fabrication Methods and Materials for mRNA-LNP Production: From Size and Morphology to Internal Structure and mRNA Delivery Performance In Vitro and In Vivo.
    Bi D; Wilhelmy C; Unthan D; Keil IS; Zhao B; Kolb B; Koning RI; Graewert MA; Wouters B; Zwier R; Bussmann J; Hankemeier T; Diken M; Haas H; Langguth P; Barz M; Zhang H
    Adv Healthc Mater; 2024 Jun; ():e2401252. PubMed ID: 38889433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A General Small-Angle X-ray Scattering-Based Screening Protocol for Studying Physical Stability of Protein Formulations.
    Zhang F; Richter G; Bourgeois B; Spreitzer E; Moser A; Keilbach A; Kotnik P; Madl T
    Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple Scattering: Lipid nanoparticle structural data repository.
    Kim LJ; Shin D; Leite WC; O'Neill H; Ruebel O; Tritt A; Hura GL
    Front Mol Biosci; 2024; 11():1321364. PubMed ID: 38584701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-angle X-ray and neutron scattering applied to lipid-based nanoparticles: Recent advancements across different length scales.
    Caselli L; Conti L; De Santis I; Berti D
    Adv Colloid Interface Sci; 2024 May; 327():103156. PubMed ID: 38643519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of non-ionizable lipids and phase mixing methods on structural properties of lipid nanoparticle formulations.
    Pratsinis A; Fan Y; Portmann M; Hammel M; Kou P; Sarode A; Ringler P; Kovacik L; Lauer ME; Lamerz J; Hura GL; Yen CW; Keller M
    Int J Pharm; 2023 Apr; 637():122874. PubMed ID: 36948476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoscopic Structure of Lipid Nanoparticle Formulations for mRNA Drug Delivery: Comirnaty and Drug-Free Dispersions.
    Unruh T; Götz K; Vogel C; Fröhlich E; Scheurer A; Porcar L; Steiniger F
    ACS Nano; 2024 Apr; 18(13):9746-9764. PubMed ID: 38514237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological Characterization of Self-Amplifying mRNA Lipid Nanoparticles.
    Thelen JL; Leite W; Urban VS; O'Neill HM; Grishaev AV; Curtis JE; Krueger S; Castellanos MM
    ACS Nano; 2024 Jan; 18(2):1464-1476. PubMed ID: 38175970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polysarcosine-Functionalized mRNA Lipid Nanoparticles Tailored for Immunotherapy.
    Wilhelmy C; Keil IS; Uebbing L; Schroer MA; Franke D; Nawroth T; Barz M; Sahin U; Haas H; Diken M; Langguth P
    Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Process Robustness in Lipid Nanoparticle Production: A Comparison of Microfluidic and Turbulent Jet Mixing.
    O'Brien Laramy MN; Costa AP; Cebrero YM; Joseph J; Sarode A; Zang N; Kim LJ; Hofmann K; Wang S; Goyon A; Koenig SG; Hammel M; Hura GL
    Mol Pharm; 2023 Aug; 20(8):4285-4296. PubMed ID: 37462906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-Time pH-Dependent Self-Assembly of Ionisable Lipids from COVID-19 Vaccines and In Situ Nucleic Acid Complexation.
    Yu H; Angelova A; Angelov B; Dyett B; Matthews L; Zhang Y; El Mohamad M; Cai X; Valimehr S; Drummond CJ; Zhai J
    Angew Chem Int Ed Engl; 2023 Aug; 62(35):e202304977. PubMed ID: 37391876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlating the Structure and Gene Silencing Activity of Oligonucleotide-Loaded Lipid Nanoparticles Using Small-Angle X-ray Scattering.
    Hammel M; Fan Y; Sarode A; Byrnes AE; Zang N; Kou P; Nagapudi K; Leung D; Hoogenraad CC; Chen T; Yen CW; Hura GL
    ACS Nano; 2023 Jun; 17(12):11454-11465. PubMed ID: 37279108
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.